| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Hesperidin | Dyslipidemia | 2 | PM | 33088721 | 📋 | Hesperidin ameliorates hepatic dysfunction and dyslipidemia in male Wistar rats exposed to cadmium chloride |
| Hesperidin | Dyslipidemia | 1 | PM | 28899694 | 📋 | Anti-atherosclerotic effect of hesperidin in LDLr -/- mice and its possible mechanism |
| Hesperidin | Hematologic Disorders | 1 | PM | 34733484 | 📋 | Ameliorative effects of hesperidin and N-acetylcysteine against formaldehyde-induced-hemato- and genotoxicity |
| Hesperidin | Hypercholesterolemia | 2 | PM | 37502716 | 📋 | The effects of hesperidin supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis |
| Hesperidin | Hypercholesterolemia | 1 | PM | 36037876 | 📋 | Molecular interactions of hesperidin with DMPC/cholesterol bilayers |
| Hesperidin | Hyperglycemia | 6 | PM | 38002199 | 📋 | Insight into the Inhibitory Mechanisms of Hesperidin on α-Glucosidase through Kinetics, Fluorescence Quenching, and Molecular Docking Studies |
| Hesperidin | Hyperglycemia | 5 | PM | 35946912 | 📋 | The Effect of Hesperidin and Diosmin Individually or in Combination on Metabolic Profile and Neuropathy among Diabetic Patients with Metabolic Syndrome: A Randomized Controlled Trial |
| Hesperidin | Hyperglycemia | 4 | PM | 33273981 | 📋 | Hesperidin prevents hyperglycemia in diabetic rats by activating the insulin receptor pathway |
| Hesperidin | Hyperglycemia | 3 | PM | 32009777 | 📋 | Hesperidin: A Therapeutic Agent For Obesity |
| Hesperidin | Hyperglycemia | 2 | PM | 31345080 | 📋 | Hesperidin, a citrus flavonoid ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats |
| Hesperidin | Hyperglycemia | 1 | PM | 26265154 | 📋 | Curcumin, Hesperidin, and Rutin Selectively Interfere With Apoptosis Signaling and Attenuate Streptozotocin-Induced Oxidative Stress-Mediated Hyperglycemia |
| Hesperidin | Hyperhomocysteinaemia | 1 | PM | 27677544 | 📋 | Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and neurotoxicity in Wistar rats |
| Hesperidin | Hyperlipidemia | 6 | PM | 38577143 | 📋 | Hesperidin Supplementation Improves Altered PON -1, LDL Oxidation, Inflammatory Response and Hepatic Function in an Experimental Rat Model of Hyperlipidemia |
| Hesperidin | Hyperlipidemia | 5 | PM | 37502716 | 📋 | The effects of hesperidin supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis |
| Hesperidin | Hyperlipidemia | 4 | PM | 35946912 | 📋 | The Effect of Hesperidin and Diosmin Individually or in Combination on Metabolic Profile and Neuropathy among Diabetic Patients with Metabolic Syndrome: A Randomized Controlled Trial |
| Hesperidin | Hyperlipidemia | 3 | PM | 34554473 | 📋 | Protective effect of hesperidin in Poloxamer-407 induced hyperlipidemic experimental rats |
| Hesperidin | Hyperlipidemia | 1 | PM | 31793010 | 📋 | Hesperidin attenuates altered redox homeostasis in an experimental hyperlipidaemic model of rat |
| Hesperidin | Hyperlipidemia | 2 | PM | 31017523 | 📋 | Citrus peel flavonoids improve lipid metabolism by inhibiting miR-33 and miR-122 expression in HepG2 cells |
| Hesperidin | Neutropenia | 1 | PM | 10364845 | 📋 | Colony stimulating factor-inducing activity of hesperidin |
| Hesperidin | Nosebleed | 1 | PM | 8376915 | 📋 | A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility |
